期刊文献+

RhoGDI2与EMT相关蛋白在结直肠癌组织中表达的临床意义及相关性 被引量:5

Clinical significance and correlation of RhoGDI2 and EMT-related proteins expression in colorectal carcinoma tissues
在线阅读 下载PDF
导出
摘要 目的探讨RhoGDI2与EMT相关蛋白(E-cadherin、Vimentin)在结直肠癌组织中表达的临床意义以及它们之间的相关性。方法收集行手术切除且随访满5年的结直肠癌患者组织标本80例。应用免疫组化法检测标本中RhoGDI2与EMT相关蛋白的表达情况,分析它们与各临床病理参数间的关系,探讨RhoGDI2与EMT相关蛋白间的相关性。结果RhoGDI2、E-cadherin、Vimentin在结直肠癌组织中的阳性表达率分别为27.5%、23.6%、48.7%。结直肠癌组织中,RhoGDI2的表达与肿瘤的浸润深度、淋巴结转移、远处转移、TNM分期及5年生存率相关(P<0.05);E-cadherin的表达与肿瘤大小、分化程度、浸润深度、淋巴结转移、TNM分期及5年生存率相关(P<0.05);Vimentin的表达与肿瘤大小、分化程度、淋巴结转移、远处转移、TNM分期及5年生存率相关(P<0.05)。结直肠癌组织中,RhoGDI2与Vimentin的表达呈正相关(r=0.295,P<0.05);RhoGDI2、Vimentin与E-cadherin的表达呈负相关(r=-0.278、r=-0.309,P<0.05)。结论 RhoGDI2与EMT相关蛋白在结直肠癌组织中的表达密切相关,我们推测RhoGDI2可能通过促进EMT的发生导致了结直肠癌的侵袭、转移及不良预后。 Objective To investigate the clinical significance and correlation of RhoGDI2 and EMT-related proteins (E-cadherin,Vimentin)expression in colorectal carcinoma tissues.Methods The tissue specimens from 80 patients that were surgical resected for CRC and follow-up for over 5 years.The expression of RhoGDI2 and EMT-related proteins (E-cadherin,Vimentin)were assessed by immunohistochemistry.The associations of their expression with clinicopatho-logical parameters and themselves were analyzed.Results The positive expression rate of RhoGDI2,E-cadherin and Vi-mentin was 27.5%,23.6%,48.7% respectively in CRC tissues.In CRC tissues,the expression of RhoGDI2 were asso-ciated with the depth of invasion,lymph node metastasis,distant metastasis,TNM stage and 5-year survival(P 〈0.05);the expression of E-cadherin were associated with the tumor size,differentiation,depth of invasion,lymph node metasta-sis,TNM stage and 5-year survival(P 〈0.05);the expression of Vimentin were associated with the tumor size,differen-tiation,lymph node metastasis,distant metastasis,TNM stage and 5-year survival(P 〈0.05).The expression of RhoG-DI2 with Vimentin showed positive correlation(r=0.295,P 〈0.05);the expression of RhoGDI2,Vimentin with E-cad-herin showed negative correlation(r=-0.278,r=-0.309,P 〈0.05).Conclusion The expression of RhoGDI2 was significantly associated with EMT-related proteins(E-cadherin,Vimentin)in CRC tissues.We speculate that RhoGDI2 may cause CRC invasion,metastasis and poor prognosis by promoting EMT occurrence.
出处 《中国实验诊断学》 2015年第9期1465-1469,共5页 Chinese Journal of Laboratory Diagnosis
基金 上海市卫计委面上项目(20114194) 吉林省发改委项目(3J113Z583429) 上海市长宁区卫计委面上项目(20114Y02003)
关键词 结直肠癌 RhoGDI2 EMT Colorectal Cancer(CRC) RhoGDI2 EMT
  • 相关文献

参考文献19

  • 1Jemal A,Center MM,De Santis C,et al. Global patterns of cancer incidence and mortality rates and trends[J]. Cancer Epidemiol Bio markers Prey, 2010,19 (8) : 1893.
  • 2代珍,郑荣寿,邹小农,张思维,曾红梅,李霓,陈万青.中国结直肠癌发病趋势分析和预测[J].中华预防医学杂志,2012,46(7):598-603. 被引量:219
  • 3Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression[J]. J Mammary Gland Biol Neoplasia, 2010, 15:117.
  • 4Acloque H,Adams MS,Fishwick K,et al. Epithelial-mesenchymal transitions:the importance of changing cell state in development and disease[J]. J Clin Invest,2009,119: 1438.
  • 5Dovas A,Couchman JR. RhoGDI:multiple functions in the regula- tion of Rho family GTPase activities[J]. Biochem J, 2005,390:1.
  • 6Lee H H, Tien SC, Jou TS, et al. Src-dependent phosphorylation of ROCK participates in regulation of focal adhesion dynamics[J]. J Cell Sel, 2010,123 : 3368.
  • 7Li X, Wang J, Zhang X, et al. Overexpression of RhoGDI2 corre lares with tumor progression and poor prognosis in colorectal car einoma[J]. J Ann Surg Oneol, 2012,19 : 145.
  • 8Van Aelst L,D'Souza-Sehorey C. Rho GTPase and signaling net works[J]. Genes Dev, 1997,11 : 2295.
  • 9Der Mardirossian C, Bokoch GM. GDIs: central regulatory mole cules in Rho GTPase activation[J]. Trends Cell Biol, 2005, 15 356.
  • 10Chuang TH, Xu X, Knaus UG, et al. GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding proteln[J]. J Biol Chem, 1993,268..775.

二级参考文献17

  • 1全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤死亡报告--全国第三次死因回顾抽样调查.北京:人民卫生出版社,2010:219-226.
  • 2Jemal A, Center MM, DeSantis C,et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epideminl Biomarkers Prev, 2010,19 (8) : 1893-1907.
  • 3Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. Lyon: International Agency for Research on Cancer, 1991:101-107.
  • 4Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. Lyon: International Agency for Research on Cancer,1994:35-49.
  • 5United Nations Department of Economic and Social Affairs, Population Division Population Estimates and Projections Section. World population prospects, the 2011 revision [ EB/OLJ. F 2012 -02 -261. http ://esa. un. ore-/unDd/wpp.
  • 6国务院全国1%人151抽样调查领导小组办公室,国家统计局人口和就业统计司.2005年全国1%人口抽样调查资料.北京:中国统计出版社,2007.
  • 7国家癌症中心,卫生部疾病预防控制局.2011中国肿瘤登记年报.北京:军事医学科学出版社,2012.
  • 8Schmid V J, Held L Bayesian age-period-cohort modeling and prediction-BAMP. J Stat Software, 2007,21 ( 8 ) : 1-15.
  • 9Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975 -2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening,and treatment) to reduce future rates. Cancer, 2010, 116 ( 3 ) : 544-573.
  • 10Cress RD, Morris C, Ellison GL, et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992 - 2001. Cancer, 2006, 107 ( 5 Suppl ) : 1142-1152.

共引文献218

同被引文献23

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部